Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults

Yang Kevin H., Satybaldiyeva Nora, Kepner Wayne, Friedman Joseph, Ping Siyuan, Leas Eric C.

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (49)

  1. Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use. 2026-01-01 · Expand citations
  2. Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use. 2026-01-01 · Expand citations
  3. Magic of the Mushrooms: Effects of Psilocybin Decriminalization. 2025-01-01 · Expand citations
  4. Psychedelic Microdosing among Young Adults from Southern California. 2025-01-01 · Expand citations
  5. Less is more? A review of psilocybin microdosing. 2024-10-01 · Expand citations
  6. Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins. 2024-03-01 · Expand citations
  7. The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. 2023-09-01 · Expand citations
  8. Microdosing psilocybin for chronic pain: a case series. 2023-04-01 · Expand citations
  9. Psychedelic Drug Legislative Reform and Legalization in the US. 2023-01-01 · Expand citations
  10. Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids. 2022-11-15 · Expand citations
  11. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. 2022-08-02 · Expand citations
  12. Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention. 2022-01-01 · Expand citations
  13. Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study. 2022-01-01 · Expand citations
  14. Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. 2021-11-18 · Expand citations
  15. Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review. 2020-12-01 · Expand citations
  16. Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities. 2020-06-01 · Expand citations
  17. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. 2020-05-01 · Expand citations
  18. Psychedelics and Psychedelic-Assisted Psychotherapy. 2020-05-01 · Expand citations
  19. Microdosing psychedelics: Motivations, subjective effects and harm reduction. 2020-01-01 · Expand citations
  20. Psychedelic Microdosing: A Subreddit Analysis. 2020-01-01 · Expand citations
  21. Microdosing psychedelics: More questions than answers? An overview and suggestions for future research. 2019-09-01 · Expand citations
  22. Psychedelic microdosing benefits and challenges: an empirical codebook. 2019-07-10 · Expand citations
  23. Motives and Side-Effects of Microdosing With Psychedelics Among Users. 2019-07-01 · Expand citations
  24. Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers. 2019-01-01 · Expand citations
  25. 10.1001/jama.2015.6358
  26. 10.1001/jamahealthforum.2024.1653
  27. 10.1001/jamanetworkopen.2021.10918
  28. 10.1001/jamanetworkopen.2023.28691
  29. 10.1001/jamapsychiatry.2025.0044
  30. 10.1007/s00213-020-05703-9
  31. 10.1007/s11136-014-0726-4
  32. 10.1007/s11606-022-07957-9
  33. 10.1016/j.amepre.2019.06.017
  34. 10.1016/j.amepre.2021.09.016
  35. 10.1016/j.amepre.2024.05.006
  36. 10.1016/j.amepre.2025.108026
  37. 10.1016/j.socscimed.2024.116702
  38. 10.1016/s0140-6736(19)31789-1
  39. 10.1038/s41598-025-03873-0
  40. 10.1080/02791072.2020.1718250
  41. 10.1080/02791072.2024.2304554
  42. 10.1089/can.2023.0084
  43. 10.1136/bmjopen-2019-035148
  44. 10.1177/0269881120940937
  45. 10.1177/13872877251389608
  46. 10.1186/s42238-025-00359-8
  47. 10.2196/36667
  48. 10.3389/fpubh.2026.1720348
  49. 10.3390/businesses1030014

Cited by — these papers cite this paper (1)

  1. Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA 2026-06-15 · Expand citations